Donate Plasma Save Lives
The group's Bangladesh plasma fractionation plant is located in the Bangabandhu Hi-Tech City, 45km from the capital city Dhaka, covering an area of 25 hectares.
Safety Quality & Efficacy
The group will devote itself to the research and development of new products and technologies,training, building a high-quality research team with professional and efficient research and development capabilities, and will cooperate with international research institutions.
A Leading Plasma Based Biopharmaceutical Company in Bangladesh
Oryx Bio-Tech is destined to be South Asia’s leading integrated human plasma biopharmaceutical group and the largest plasma derived products also known as Life-Saving therapeutics manufacturer in Bangladesh. The Oryx Plasma Fractionation Plant will be located on the already acquired land in the Bangabandhu Hi-Tech City at Kaliakoir, 45km from the capital city Dhaka, covering an area of 25 acres. Presently under development, the plant’s plasma processing capacity will reach 2,800,000 vials per year.
Oryx's mission is to establish and facilitate a vital connection between donor and recipient by collecting and transforming plasma.
Plasma Processing Capacity
Achievement [at a Glance]
We believe social responsibility must be expressed pro-actively, that is, it is not enough simply to “do no harm”; we should be looking for and be aware of opportunities to do positive “good” in the world, whether it is the world of our plants and facilities, our donors and derivative users or the global environment.
- The CFDA Standard
- The WHO Regulations
- The ISO 26000 Guidelines
- The ISO 9001 Standards
- The ISO 14001 Standards
- The Global Compact's Ten Principles regarding human rights, labor, the environment and the fight against corruption.